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ABSTRACT
A novel class of non-nucleoside triphosphate
analogues, bearing hydrophobic groups sterically
similar to nucleosides linked to the a-phosphate but
lacking the chemical functional groups of nucleic
acids, were tested against six different DNA poly-
merases (polymerases). Human polymerases a, b
and l, and Saccharomyces cerevisiae polymerase
IV, were inhibited with different potencies by these
analogues. On the contrary, Escherichia coli poly-
merase I and HIV-1 reverse transcriptase were not.
Polymerase b incorporated these derivatives in a
strictly Mn11-dependent manner. On the other hand,
polymerase l could incorporate some alkyltriphos-
phate derivatives with both Mg11 and Mn11, but
only opposite to an abasic site on the template strand.
The active site mutant polymerase l Y505A showed an
increased ability to incorporate the analogues. These
results show for the first time that neither the base nor
the sugar moieties of nucleotides are required for
incorporation by family X DNA polymerases.
INTRODUCTION
During DNA synthesis, any DNA polymerase is presented
with a pool of four structurally similar deoxynucleotide
triphosphates (dNTPs) from which it must select the sole
Watson–Crick base-paired (correct) substrate for incorpora-
tion into the growing DNA strand (1). The identity of such a
correct dNTP changes with each cycle of nucleotide incorp-
oration, as translocation along the DNA strand presents a
new ‘templating’ base to the enzyme’s active site. Most
polymerases are accurate, with error frequencies for nucleot-
ide incorporation ranging from 103 to 106. However, a
Watson–Crick base pair is only 0.2–4 kcal/mol more stable
than a mismatched base pair in free solution, accounting for
discrimination efficiencies between incorrect and correct base
pair of 102 (2). Indeed, studies with nonpolar analogues of
nucleotides have shown that replication can proceed effi-
ciently even in the absence of hydrogen bonds (3–7). This
led to the ‘steric-exclusion’ or ‘induced-fit’ model for fidelity
of incorporation, whereby neither Watson–Crick hydrogen
bonds nor canonical purine and pyrimidine structures are
required for enzymatic synthesis of nascent base pairs (8,9).
This model predicts that a combination of the active site size
(steric exclusion) and flexibility (tightness) drives the select-
ivity of nucleotide incorporation (10). This model has been
substantiated by studies showing efficient incorporation of a
large pyrene deoxynucleoside triphosphate in front of an aba-
sic (AP) site by Escherichia coli polymerase I (Klenow frag-
ment, KF) and T7 polymerase (11). Furthermore, C40-alkyl-
substituted dTTP analogues were used to show that increasing
the size of the sugar ring also leads to steric exclusion (12–15).
Polymerases in families A, B, X and RT have binding pockets
that tightly accommodate a correct Watson–Crick base pair,
supporting the notion that nucleotide selectivity for these
enzymes largely depends on geometric selection for the
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shape and size of correct base pairs (16,17). Based on the
crystal structures of binary and ternary complexes of poly-
merases with their substrates, it has been proposed that after
the initial encounter between a dNTP and the polymerase–
DNA binary complex, a rate-limiting transition from the open
to the closed polymerase conformation would carry the dNTP
into the active site where it would encounter the templating
base. A correct complementarity would stabilize the catalyt-
ically competent close conformation (18–20). However, recent
data have shown that some family X polymerases are excep-
tions. For example, kinetic studies have suggested that there is
no rate-limiting step preceding catalysis for polymerase b (21),
whereas crystallographic studies have shown that the related
enzyme polymerase l appears to be in a ‘closed’ conformation
even in the absence of a bound dNTP (22). Understanding the
mechanisms underlying the base selectivity of polymerases
b and l will have important implications also in light of
their ability to overcome lesions on the template strand,
such as AP sites and cisplatin adducts.
Recently, a novel class of non-nucleoside triphosphate
analogues has been developed, in which the a-phosphate
was esterified to bulky hydrophobic groups sterically similar
to nucleosides but lacking the chemical functional groups of
nucleic acids (23,24). These analogues have been shown to be
efficient substrates for the template-independent polymerase
terminal-deoxynucleotidyl transferase (TdT), another member
of the polymerase family X, leading to the suggestion that the
base moiety did not participate significantly in dNTP binding
to the active site of TdT, whereas the main contribution was
made by the triphosphate moiety (23,24). Both polymerase b
and polymerase l share significant sequence and structural
similarity with TdT (25). Moreover, polymerase l possesses
a template-independent terminal transferase (tdt) activity, in
addition to the normal template-dependent polymerase activ-
ity (26). We were interested in investigating the ability of
template-dependent polymerases to bind and eventually
incorporate such non-nucleoside triphosphate analogues. In
fact, no reports to date have shown that template-dependent
DNA polymerases can incorporate triphosphate analogues
lacking both the sugar and the nucleobase. Such analogues
might help to further define the minimal requirements for
incorporation by DNA polymerases. To this aim, we synthes-
ized novel alkyltriphosphate analogues, bearing different sub-
stituents esterified at the a-phosphate position (Figure 1), and
tested them in the presence of polymerases from the A, B, X
and RT families, on undamaged and AP sites-containing DNA
Figure 1. Structures of the compounds used in this study. (A) Ia-d fluorenylmethoxycarbonyl-derivatives. (B) IIa-b butyl-derivatives. (C) III benzoyloxyl-derivative.
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substrates. Our results showed that neither the base nor the
sugar moieties of a nucleotide are an essential feature for its
incorporation. Moreover, the incorporation efficiency
depends on the particular enzyme, on the structure of the
non-nucleoside analogue, on the metal activator and on the
nature of the DNA template.
MATERIALS AND METHODS
Chemicals
[3H]dTTP (30 Ci/mmol) and [g-32P]ATP (3000 Ci/mmol)
were from Amersham Biosciences; unlabelled dNTPs,
poly(dA) and oligo(dT)12–18 were from Roche Molecular
Biochemicals. The oligonucleotides were from MWG Biotech
(Florence, Italy). Whatman was the supplier of the GF/C
filters. All other reagents were of analytical grade and
purchased from Merck or Fluka.
Chemistry
Compounds Ia-c were synthesized by the reaction of the
corresponding amino alcohols with 9-fluorenylmethyl chloro-
formate and subsequent phosphorylation by the Ludwig
procedure without isolating intermediate monophosphates
(27,28). Product Id was obtained in a similar manner from
hexane-1,6-diol (Scheme 1).
Isolation and purification of the synthesized compounds
were carried out using a Dowex-50 (NH4)
+ column followed
by reverse-phase chromatography on LiChroprep RP-18.
Compound III was synthesized by phosphorylation of
4-hydroxybutyl ester of benzoic acid according to the Ludwig
procedure. Compounds IIa and IIb were obtained by hydro-
lysis of compounds Ic and III, respectively.
Nucleic acid substrates
The 73mer DNA oligonucleotide, either undamaged or
containing the synthetic (tetrahydrofurane) AP site, and the
corresponding primers were chemically synthesized and puri-
fied on denaturing polyacrylamide gel. The sequence of the
d73mer is shown as follows: 50-GATCGGGAGGGTAGGAA-
TATTGAG[X/G]ATGAAGGGTTGAGTTGAGTGGAGAT-
AGTGGAGGGTAGTATGGTGGATA-30.
The sequences complementary to the 17 and 18mer primers
are single- and double underlined, respectively. In brackets,
the position of the lesion or the corresponding G residue in the
undamaged template is indicated in bold letters (X, AP site).
The d66mer and d24mer oligonucleotides were purchased
from Roche Molecular Biochemicals. The sequence of the
d66mer is shown as follows: 50-AGGATGTATGTTTAG-
TAGGTACATAACTATCTATTGATACAGACCTAAAAC-
AAAAAATTTTCCGAG-30.
The sequence complementary to the d24mer is underlined.
Enzymes and proteins
Recombinant full-length human polymerase l and the poly-
merase l Y505A mutant were generated and purified as
described previously (29–31). After purification, the proteins
were >90% homogenous, as judged by SDS–PAGE and
Coomassie staining (data not shown). Human polymerase a
and HIV-1 RT were purified as described previously (32,33).
Human polymerase b and calf thymus TdT were from Trevi-
gen. E.coli polymerase I (KF) was from Roche Molecular
Biochemicals.
Enzymatic assays
DNA polymerase assay. Human polymerase l and Saccharo-
myces cerevisiae polymerase IV activity on poly(dA)/
oligo(dT)10:1 were assayed in a final volume of 25 ml contain-
ing 50 mM Tris–HCl (pH 7.0), 0.25 mg/ml BSA, 1 mM DTT,
0.5 mM MnCl2, 0.2 mM poly(dA)/oligo(dT)10:1 (30-OH ends),
50 nM polymerase l and 5 mM [3H]dTTP (5 Ci/mmol), unless
otherwise indicated in the figure legends. All reactions were
incubated for 15 min at 37C unless otherwise stated and the
DNA precipitated with 10% trichloroacetic acid. Insoluble
radioactive material was determined by scintillation counting
as described previously. Polymerase b, polymerase a, E.coli
polymerase I (KF) and HIV-1 RT activities were assayed as
described previously (29).
Terminal deoxyribonucleotidyl transferase assay. Polymerase
l and TdT terminal transferase activities were assayed in a
final volume of 25 ml containing 50 mM Tris–HCl (pH 7.0),
0.25 mg/ml BSA, 1 mM DTT, 0.5 mM MnCl2 and 0.2 mM of
single-stranded 30mer DNA oligonucleotide, unless otherwise
stated. Enzymes and [3H]dNTPs (10 Ci/mmol) were added as
indicated in the figure legends. All reactions were incubated
at 37C for 10 min., unless otherwise indicated in the figures
and the DNA precipitated with 10% trichloroacetic acid.
Insoluble radioactive material was determined by scintillation
counting as described previously (34).
When 50-32P-labelled substrates were used, reactions were
performed as described above in the presence of 0.2 mM (30-
OH end) of the labelled substrate and unlabelled dNTPs as
indicated in the figure legends. All reactions were incubated
for 15 min at 37C unless otherwise stated and resolved on
14% polyacrylamide–7 M urea. Reactions products were visu-
alized and quantified by storage phosphor analysis with a
Molecular Dynamics PhosphorImager using ImageQuant
version 5.2 software.
Inhibition assays
Reactions were performed under the conditions described for
the terminal deoxyribonucleotidyl transferase activity assay.
Incorporation of radioactive dTTP into poly(dA)/oligo(dT) at
different concentrations of DNA or dNTP was monitored in
the presence of increasing amounts of inhibitor as indicated in
the figure legends. Dose–response curves were generated by
computer fitting of the data to the Equation 1:
E %ð Þ ¼ Emax
1 þ I
ID50
  12) (Bu3NH)2H2P2O7
1) POCl3 IdFmocNH(CH2)6OH
1) FmocCl
1) MsCl 2) NaN3
3) HO(CH2)2SH
HO(CH2)6OH
MMTrCl
HO(CH2)6OMMTr
H2N(CH2)6OMMTr 2) H+
Scheme 1. Schematic diagram of compound Id chemical synthesis.
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where E(%) is the fraction of enzyme’s activity measured in the
presence of the inhibitor, Emax is the activity in the absence of
the inhibitor, I is the inhibitor concentration and ID50 is the
inhibitor concentration at which E(%) ¼ 0.5Emax.
Steady-state kinetic analysis
The Km and kcat values were calculated according to the
Briggs–Haldane model. Inhibition data were analysed accord-
ing to the equation for the fully competitive mechanism of
inhibition. Ki values were calculated from the variation of the
values of the apparent affinities for the competing substrate
(Kapp values) as a function of the inhibitor concentrations,
according to Equation 2:
Kapp ¼ Km
Ki
ƒ I½ 
 þ Km: 2
Initial velocities of the reaction were determined after
10 min of incubation at 37C, which represent the mid-
point of the linear range of the reaction, as determined in
separate experiments (data not shown). Each experiment
was performed in triplicate, and mean values were used for
the analysis. Curve fitting was made using the computer
program GraphPad Prism.
RESULTS
Non-nucleoside alkyltriphosphate analogues are able to
inhibit different DNA polymerases
Novel substituted alkyltriphosphates analogues were synthes-
ized (Figure 1, compounds I–III) and tested as inhibitors
of various polymerases, such as human polymerase a, poly-
merase b, polymerase l (both for its activity as a polymerase
and as a terminal transferase), polymerase I of E.coli, poly-
merase IV of S.cerevisiae (Sc) and HIV-1 reverse transcriptase
(RT). The results are summarized in Figure 2. All compounds
were unable to inhibit the polymerase activity of E.coli poly-
merase I and HIV-1 RT. Compound IIa did not affect the
polymerase activity of any of the enzymes tested. However,
the other compounds were able to repress the polymerase
activity of polymerase a, polymerase b, polymerase l and
Sc polymerase IV, albeit with different potencies. It has
been shown that polymerase l is endowed with both a
template-dependent (i.e. DNA polymerase) and a template-
independent (i.e. terminal transferase) activity (26). Interest-
ingly, the alkyltriphosphate analogues were able to inhibit
polymerase l both as a polymerase and as a terminal
transferase.
Non-nucleoside alkyltriphosphate analogues are
competitive inhibitors of DNA polymerases
with respect to the nucleotide substrate
In order to determine the precise mechanism of inhibition, the
active compounds were titrated in a polymerase assay in the
presence of increasing DNA or nucleotide substrates concen-
trations. The inhibitors caused an increase in the apparent
affinity for the nucleotide substrate (Ks), whereas the Vmax
of the reaction was unaffected. By plotting the apparent Ks
values (Ksapp) obtained in the presence of the inhibitors, as a
function of the inhibitor concentrations, the corresponding Ki
values were calculated and reported in Table 1. When analysed
in the presence of different DNA substrate concentrations, the
active compounds caused a reduction in the Vmax of the reac-
tion, without affecting the apparent affinity of the enzyme for
the substrate (data not shown). Thus, all the compounds
proved to be competitive inhibitors with respect to the nuc-
leotide substrate and non-competitive inhibitors with respect
to the DNA substrate.
Non-nucleoside alkyltriphosphate analogues are not
incorporated into a normal DNA template by DNA
polymerase a, DNA polymerase l and S.cerevisiae DNA
polymerase IV
Next, we investigated whether the alkyltriphosphate analogues
could be incorporated into the growing DNA chain by
the different polymerases, or if these compounds were non-
substrate inhibitors of the enzymes. To this aim, incorporation
was monitored on the 50-labelled heteropolymeric DNA
Figure 2. Alkyltriphosphate analogues are inhibitors of the nucleotide incorporation reaction catalysed by various DNA polymerases. The different compounds were
tested at 200 mM final concentration in the presence of polymerase a (0.1 U), polymerase b (100 nM), polymerase l (100 nM), Sc polymerase IV (200 nM), E.coli
polymerase I (0.1 U) and HIV-1 RT (50 nM), under the conditions described in Materials and Methods. Since the molar concentration of polymerase a and
polymerase I was not known, the amount added is expressed in Units. However, in all instances the amounts used for each enzyme resulted in similar values of pmols
of dTMP incorporated in the control reactions. One unit of enzyme is equivalent to the incorporation of 1 nmol dTMP/h. Values are the means of three independent
experiments; error bars represent SD units.
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primer–template d24/d66mer and the reaction products were
visualized on a sequencing gel. As shown in Figure 3A (lanes
1–7), none of the compounds was incorporated into the nucleic
acid chain by polymerase l polymerase activity. Similarly,
polymerase a and Sc polymerase IV were unable to incorp-
orate the compounds (data not shown). Next, we evaluated
whether the inability of the different polymerases to incorp-
orate the alkyltriphosphate analogues was due to the nature of
the templating base. The d24/d66mer used in the experiments
described above had the base guanosine at +1 position (see the
sequence in Figure 3A). In order to evaluate the incorporation
of the compounds on substrates having different bases at
+1 position, we incubated our substrate d24/d66mer with
dCTP at 37C for 10 min, to obtain the extension of the primer
of just one base so as to have adenine as the base at +1 position
(Figure 3A, lanes 8–11). Similarly, incubating our template in
the presence of both dCTP and dTTP resulted in a primer
extended by 2 nt, with cytosine being the base at +1 position
(Figure 3A, lanes 12–14), whereas addition of dCTP, dTTP
and dGTP resulted in a primer extended by 4 nt, with thymi-
dine as the templating base at +1 position (Figure 3A, lanes
16–19). Primer extension reactions by polymerase l in the
presence of the different combinations of dNTPs were per-
formed for 5 min at 37C. Then, alkyltriphosphate analogues
were added and the reaction was incubated for additional
20 min. As shown Figure 3A, the compounds were not incor-
porated by polymerase l, no matter which base was present
at the +1 position. Identical results were obtained with poly-
merase a and Sc polymerase IV (data not shown).
The ability of DNA polymerase l to incorporate the
alkyltriphosphate analogues depends both on the
structure of the inhibitor and on the presence
of an abasic site in the template strand
The results shown in Figure 3A indicated that alkyltriphos-
phate analogues were not incorporated into the nucleic acid
chain, although they were competitive inhibitors with respect
to the nucleotide substrate (Figure 2 and Table 1). One
possibility could be that, even though they can bind to the
enzyme’s nucleotide binding pocket, due to their unusual
structures they cannot be properly aligned with the 30-hydroxyl
end of the primer, thus preventing phosphodiester bond forma-
tion. However, we hypothesized that, in the presence of par-
ticular DNA template/primer structures, the block towards the
transition to a catalytically competent ternary complex could
be removed and the analogues incorporated. It is known
that polymerase l can efficiently perform translesion
synthesis in the presence of an AP site on the template strand
(35). Owing to the lack of the base moiety, an AP site is
considered a non-instructional lesion, and the steric require-
ments for the alignment and incorporation of an incoming
nucleotide in front of an AP site are different from those
operating in the presence of a templating base. Thus, we
asked whether an AP site would allow incorporation of alkyl-
triphosphate analogues. To this aim, we employed the hetero-
polymeric DNA primer–template d18/d73mer as a substrate
for our incorporation assay, which bears either a G or a syn-
thetic AP site (tetrahydrofurane moiety) at +1 position. As
shown in Figure 3B, polymerase l (as a polymerase) was
unable to incorporate any of the compounds on the intact
template, as expected (lanes 5–8), but showed clear incorp-
oration of the compound III opposite to an AP site (lane 2). On
the other hand, Sc polymerase IV and human polymerase a
were unable to incorporate the alkyltriphosphate analogues,
either in the absence or in the presence of an AP site (data not
shown).
The mutation Y505A in the active site of DNA
polymerase l allows incorporation of different
non-nucleoside alkyltriphosphate analogues
in the presence of an abasic site
We have previously shown that the residue Tyr 505 in the
polymerase l catalytic site is important for nucleotide binding
(30). Resolution of the 3D structure of the enzyme showed
that the Tyr 505 side chain contributes to determine the
size and geometry of the nucleotide binding pocket of
polymerase l (22). We, therefore, investigated whether the
substitution of Tyr 505 with a shorter Ala side chain had any
effect on the binding and incorporation of alkyltriphosphate
analogues.
As summarized in Table 1, the compounds Ia–d, IIb and III
showed potencies of inhibition 10- to 75-fold higher towards
the Y505A mutant than towards the wild-type enzyme. Thus,
an increase in the size of the nucleotide binding site of poly-
merase l correlated with a tighter binding of the alkyltriphos-
phate analogues. Starting from these observations, we tested
whether polymerase l Y505A, as a polymerase, could incorp-
orate any of the alkyltriphosphate analogues. As shown in
Table 1. Inhibition constants for alkyltriphosphate analogues towards DNA polymerases
Inhibitor Enzyme
Ki (mM)a Polymerase a Polymerase b Polymerase l Polymerase l Y505A Polymerase l-tdt ScPol IV
+1 mM Mn++ +1 mM Mg++ +1 mM Mn++ +1 mM Mg++
Ia n.d.b 10 (±1) >400 4.5 (±0.7) 5.6 (±0.9) 0.74 (±0.05) 1.5 (±0.2) 0.45 (±0.02)
Ib n.d. 63 (±5) n.d. 2.2 (±0.2) n.d. 0.07 (±0.01) 0.4 (±0.06) 0.25 (±0.03)
Ic 112 (±15) 71 (±9) n.d. 2.1 (±0.3) n.d. 0.09 (±0.01) 0.25 (±0.05) 0.35 (±0.03)
Id 145 (±5) n.d. n.d. 2 (±0.2) n.d. 0.03 (±0.002) 0.5 (±0.06) 0.25 (±0.05)
IIa n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
IIb n.d. 39 (±3) >400 9 (±1) 22 (±1) 0.87 (±0.07) 4.7 (±0.5) 29 (±4)
III n.d. n.d. n.d. 1.5 (±0.2) 2.2 (±0.2) 0.35 (±0.02) 1.4 (±0.1) 2.2 (±0.3)
aInhibition constant (Ki) values are the means of three independent experiments and were determined as described in Materials and Methods. Numbers in
brackets are ±SD.
bn.d., not determined.
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Figure 4A, polymerase l Y505A was not able to incorporate
any of the compounds tested on a normal substrate (lanes 1–8),
similarly to the wild-type form of the enzyme. However, after
the incubation of the mutant enzyme with an AP substrate, the
mutant Y505A was able to incorporate not only compound III
(lane 11), as the wild-type enzyme, but also the compounds
Ia–c (lanes 12–14).
DNA polymerase l as a terminal transferase is
not able to incorporate any non-nucleoside
alkyltriphosphate analogue
The results obtained with the AP site substrate seemed to
indicate that a major barrier for the alkyltriphosphate
analogues incorporation by polymerase l was of steric nature,
particularly with respect to the presence of a templating base.
Figure 3. Alkyltriphosphate analogues are incorporated by DNA polymerase l in the presence of an AP site only. (A) Polymerase l (100 nM) was incubated in the
presence of the 50-labelled d24/d66mer DNA template and 50 mM of the various compounds without any preincubation (lanes 1–7) or was preincubated 5 min in
the presence of DNA template and 10 mM dCTP (lanes 8–11), 10 mM dCTP and dTTP (lanes 12–15), 10 mM dCTP, dTTP and dGTP (lanes 16–19), before addition of
the compounds to be tested. Lane 20, control reaction with all four dNTPs; lane C, labelled template and enzyme only. (B) Polymerasel (100 nM) was incubated in the
presence of the 50-labelled d18/d73mer DNA template either undamaged (lanes 5–8) or with an AP site at position +1 (lanes 1–4), and in the presence of 100 mM
compound Ic (lanes 3 and 8), III (lanes 2 and 7), IIb (lanes 1 and 6) or 0.5 mM dCTP (lanes 4 and 5). Lane C, labelled template and enzyme only.
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Since polymerase l is also able to incorporate nucleotides in a
template-independent manner, through its tdt activity, we next
investigated whether polymerase l tdt was able to incorporate
alkyltriphosphate analogues into a single-stranded DNA chain.
As a substrate for the incorporation reaction, we used a single-
stranded DNA 30mer oligonucleotide, which proved to be
an efficient substrate for dTTP incorporation by polymerase
l tdt (26). As a positive control, we used calf thymus
TdT (A. Khandazhinskaya, M. Jasko, L. Alexandrova and
M. Kukhanova, manuscript in preparation).
As shown in Figure 4B, although the TdT enzyme was able
to incorporate the alkyltriphosphate analogues as expected
(lanes 16–18), no incorporation was detected with polymerase
l tdt, either wild-type (lanes 1–7) or the Y505A mutant
(lanes 8–15).
DNA polymerase b is able to incorporate different
non-nucleoside alkyltriphosphate analogues either in
the absence or in the presence of an abasic site
Polymerase l belongs to the DNA polymerase family X, along
with TdT, Sc polIV and polymerase b. The results shown
above already highlighted important differences among poly-
merase l and its relatives TdT and Sc polIV, with respect to
the incorporation of alkyltriphosphate analogues. As summar-
ized in Table 1, polymerase b activity was also inhibited by
compounds Ia–c and IIb. It was, thus, of interest to investigate
the behaviour of polymerase b in the presence of the same
compounds. As shown in Figure 5A, polymerase b proved to
be able to incorporate compounds Ia–c either in the absence
(lanes 2–4) or in the presence (lanes 7–9) of an AP site. On the
other hand, Compound Id was not incorporated. These results
indicated a clear difference in the mechanism of nucleotide
selection within the polymerase X family, between poly-
merase b, polymerase l and Sc polymerase IV.
DNA polymerase b, DNA polymerase l wild-type
and the DNA polymerase Y505A mutant show different
specificities for alkyltriphosphate analogues
incorporation
The results shown above indicated that both polymerase l and
polymerase l Y505A were able to incorporate compound III,
but only in the presence of an AP site on the template strand. In
Figure 4. The Y505A mutation increases the ability of incorporation of alkyltriphosphate analogues by DNA polymerase l as a polymerase but not as a terminal
transferase. (A) The polymeraselmutant Y505A (100 nM) was incubated in the presence of the 50-labelled d18/d73mer DNA template either undamaged (lanes 1–8)
or with an AP site at position+1 (lanes 9–16), and in the presence of 100mM compound IIb (lanes 2 and 10), III (lanes 3 and 11), Ia (lanes 4 and 12), Ib (lanes 5 and 13),
Ic (lanes 6 and 14), Id (lanes 7 and 15) or 0.5mM dCTP (lanes 8 and 16). Lanes 1 and 9, labelled template and enzyme only. (B) An aliquot of 100 nM of polymerase l
wild-type (lanes 1–7), of the polymerase l mutant Y505A (lanes 8–15) or 0.1 U of calf thymus TdT (lanes 16–18), were incubated in the presence of the 50-labelled
d30mer single-stranded DNA template and 50 mM of compound Ia (lanes 1 and 8), Ib (lanes 2 and 9), Ic (lanes 3, 10 and 16), Id (lanes 4 and 12), IIb (lanes 5 and 13),
III (lanes 6, 14 and 17) , or 0.5 mM dTTP (lanes 7, 15 and 18). Lane C, labelled oligo and enzyme only.
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addition, polymerase l Y505A was also able to incorporate
compounds Ia–c in front of an AP site. Conversely, poly-
merase b could not utilize compound III, but was able to
incorporate compounds Ia–c both in the absence and in the
presence of an AP site. In order to better understand the
molecular basis for these different specificities, we determined
the kinetic parameters (Km, kcat and kcat/Km) for alkyltriphos-
phate analogue incorporation of polymerase b, polymerase l
and polymerase l Y505A. The calculated values are reported
in Table 2. As can be seen, polymerase l wild-type mutant
incorporated compound III with a 380-fold lower efficiency
than dCTP in front of the AP site. This large difference was
reflected by a higher Km value of compound III with respect to
dCTP. The mutation Y505A improved the efficiency of
incorporation of compound III of 4-fold, with an increase
in the apparent affinity (lower Km value) of compound III for
the polymerase l mutant. Polymerase b incorporated com-
pound Ic on the undamaged template (i.e. with a G on the
template strand) with a 60-fold lower efficiency than dCTP.
Again, this low incorporation efficiency was reflected by a
Figure 5. DNA polymerase b, but not DNA polymerase l, can incorporate
alkyltriphosphate analogues in a Mn++-dependent manner exclusively. (A)
Polymerase b (100 nM) was incubated in the presence of the 50-labelled
d18/d73mer DNA template either undamaged (lanes 6–10) or with an AP site
at position+1 (lanes 1–5), and in the presence of 200mM of compound Ia (lanes
2 and 7), Ib (lanes 3 and 8), Ic (lanes 4 and 9), Id (lanes 5 and 10) or 20mM dCTP
(lanes 1 and 6). Lane C, labelled template and enzyme only. (B) An aliquot of
100 nM of polymerase l or polymerase bwere incubated in the presence of the
50-labelled d18/d73mer DNA template either undamaged (lanes 6 and 7) or with
an AP site at position +1 (lanes 1–5), and in the presence of 100 mM compound
III (lane 3), 200 mM compound Ia (lanes 5 and 7) or 0.5 mM dCTP (lanes 2
and 4). Lane 1, labelled template and enzyme only.
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large difference in the apparent binding constant (Km) between
dCTP and compound Ic. Interestingly, both polymerase l
Y505A and polymerase b incorporated compound Ic in
front of an AP site with similar apparent binding affinities
(Km) and catalytic rates (kcat) to dCTP, resulting in nearly
the same efficiency. This indicated that the presence of a
templating base played a key role in determining the specifi-
city of incorporation of the alkyltriphosphate analogue Ic ver-
sus a canonical nucleotide.
The binding and incorporation of alkyltriphosphate
analogues depends on Mn++ as the metal activator
for DNA polymerase b but not for DNA polymerase l
All the experiments discussed above for polymerase b and
polymerase l were performed in the presence of Mn++,
which is the optimal metal coactivator for both enzymes
in vitro. However, it is well known that Mn++ can alter the
fidelity of DNA synthesis by polymerase b. In addition, kinetic
and structural studies have revealed differences in the utiliza-
tion of Mn++ and Mg++ between polymerase b and polymerase
l (36,29). In order to investigate whether the observed effects
of alkyltriphosphate analogues were dependent on the metal
coactivator, inhibition studies were performed in the presence
of Mg++ for some representative compounds. As reported in
Table 1, inhibition of polymerase l was not significantly
affected by replacement of Mn++ with Mg++. However, poly-
merase b, in the presence of Mg++, became completely res-
istant to inhibition. Accordingly, polymerase lwas still able to
incorporate compound III in front of an AP site in the presence
of Mg++ (Figure 5B, lanes 1–3), whereas polymerase b could
not incorporate compound Ia either in the presence or in the
absence of an AP site (Figure 5B, lanes 4–7).
DISCUSSION
We have employed non-nucleoside triphosphate analogues
bearing different substituents at the a-phosphate (Figure 1)
as means to probe the ability of template-dependent poly-
merases to bind and incorporate triphosphates lacking both
the sugar and the base moieties. This information could
be helpful in determining the minimal requirements for
incorporation by template-dependent DNA polymerases.
The substituents esterified to the a-phosphate in place of
the nucleoside moiety ranged from relatively small and hydro-
philic groups (as in compounds IIa and IIb) to bulky hydro-
phobic molecules (as in compounds Ia–d and III). As shown
in Figure 2 and Table 1, polymerase a (family A) and poly-
merase b, polymerase l and Sc polymerase IV (family X) were
inhibited by some of the tested compounds, whereas E.coli
polymerase I (KF) (family A) and HIV-1 RT were completely
unaffected. The inhibition was competitive with the nucleotide
substrate in all cases, indicating binding of the tested com-
pounds to the enzyme’s nucleotide binding pocket. In the case
of polymerase l and Sc polymerase IV, the potency of inhibi-
tion increased with the length of the alkylic chain, whereas
polymerase b showed an opposite trend (Table 1). Compounds
Ic, IIa, IIb and III are 1,4-butylidene-triphosphate derivatives
(Figure 1) bearing different substituents. It can be seen that for
polymerase l and Sc polymerase IV, the inhibition potencies
increased with an increase in the size and hydrophobicity of
the substituent (compare compound III with compound Ic in
Table 1). Again, polymerase b behaved differently, since com-
pound III was totally inactive, whereas compound IIb was
more active than Ic (Table 1). Thus, even though one has to be
cautious in drawing general conclusions, our results suggest
that binding of alkyltriphosphate analogues to polymerase l
and Sc polIV positively correlated with the length of the
alkylic chain and the size and hydrophobicity of the substitu-
ent, whereas binding to polymerase b showed an opposite
trend. As shown by structural studies, DNA polymerase
b undergoes open-to-closed conformational transition when
binding a dNTP (37,38), whereas polymerase l adopts always
a ‘closed’ structure even in the absence of substrates (39).
Thus, it is possible to hypothesize that an increased spacing
between the fluorenylmethoxy substituent and the triphosphate
moiety in compounds Ia–d would inhibit polymerase b, by
impairing its open-to-closed conformational transition, but not
polymerase l which seems not to be dependent on such trans-
ition. The significantly lower potencies of inhibition showed
by some compounds towards polymerase a with respect
to polymerase l and polymerase b suggest that family B
polymerases are more efficient in discriminating against
non-nucleoside triphosphate analogues than family X
enzymes.
Kinetic and structural studies have shown that the residue
Tyr 505 of polymerase l plays an important role in dNTP
binding (30). In the DNA template–polymerase l binary com-
plex, Tyr 505 obstructs the nucleotide binding pocket through
an hydrogen bond with the templating base (39). The alkyl-
triphosphate analogues showed potencies of inhibition 10- to
75-fold higher towards the polymerase l Y505A mutant,
where the Tyr side chain has been replaced by a shorter
Ala, than towards the wild-type enzyme (Table 1). Interest-
ingly, the largest effect was observed for compounds Ia–d,
bearing the large fluorenylmethoxy substituent. The better
fitting of this bulky substituent in the larger nucleotide binding
pocket of the Y505A mutant polymerase l supports the notion
of a steric-check based mechanism for discrimination against
this non-nucleoside analogue.
Interestingly, polymerase l was able to incorporate only
compound III and exclusively when presented with an AP
site on the template strand. Replacement of Try 505 with
Ala also allowed incorporation of compounds Ia–c by the
mutant Y505A but always only in front of an AP site, i.e.
in the absence of a templating base. As reported in Table 2,
incorporation of compound Ic in front of the AP site by poly-
merase l Y505A occurred with an efficiency identical to the
nucleotide substrate dCTP. We have already shown that poly-
merase l bypasses an AP site by a template-slippage mech-
anism, using the base downstream the lesion as the templating
one (40). Thus, dCTP incorporation in the presence of the AP
site in our experiments was driven by the G at position +2 of
the template (Figures 3C and 4A). Conversely, compound
Ic was likely incorporated in front of the lesion, since we
could not detect incorporation of any of the alkyltriphosphate
analogues opposite to any of the four bases A, T, G and C
(Figure 3A) by polymerase l. It has to be mentioned here that,
in all cases, the incorporated analogues could not be elongated,
thus acting as true chain terminators of the DNA synthesis
reaction (data not shown).
Nucleic Acids Research, 2005, Vol. 33, No. 13 4125
DNA polymerase b was able to incorporate compounds
Ia–c independently from the presence of an AP site on the
template, but this effect was strictly dependent on Mn++ as the
metal activator. Structural studies have shown that in the pres-
ence of Mn++, the nucleotidyl transfer reaction by polymerase
b takes place in a random manner without the need for instruc-
tions from the template (36). When polymerase b was tested in
the presence of Mg++ as the metal activator, it was completely
unable to bind and incorporate the alkyltriphosphate analogues
(Table 1 and Figure 5). Conversely, in the presence of Mg++,
polymerase l was able to bind and incorporate our compounds
in a very similar manner as in the presence of Mn++ (Table 1
and Figure 5). The crystal structure of the ternary polymerase
l-DNA–dNTP complex showed only one Mg++ ion coordin-
ated with the a, b and g phosphates of the incoming dNTP
(39), contrary to the two metals usually present in polymerase
b structures (37,38). Thus, it is possible that either one Mg++ or
one Mn++ might bind to polymerase l without causing a sig-
nificant alteration of the active site. However, the differences
in size, binding and reactivity between Mn++ and Mg++ ions
are exacerbated in polymerase b, which requires two metal
ions for catalysis.
DNA polymerase l also possesses a template-independent
tdt-like activity, which was potently inhibited by all the com-
pounds tested, with the exception of IIa (Table 1). However,
the tdt activity of polymerase l, either wild-type or the Y505A
mutant, was completely unable to incorporate any of the tested
compounds, contrary to TdT (Figure 4B). Superimposition of
the available crystal structures of human polymerase l and
murine TdT revealed a number of differences in the nucleotide
binding pocket (22,39,41). Thus, the different nature of the
amino acid side chains involved in stabilization of the incom-
ing dNTP might explain the different behaviour of polymerase
l-tdt and TdT with respect to alkyltriphosphate analogues
incorporation.
In summary, our results showed that both the nucleobase
and the ribose sugar are neither essential for binding nor for
incorporation by family X DNA polymerases and can be sub-
stituted by hydrophobic molecules of a suitable size. The
incorporation efficiencies of the alkyltriphosphate analogues
did not correlate with their binding affinities to the different
polymerases. For example, polymerase l, polymerase a and
Sc polymerase IV were able to bind but not to incorporate the
tested compounds on a normal DNA template, irrespectively
from the identity of the templating base. Thus, binding
of the non-nucleoside triphosphate analogues to the DNA–
polymerase complex can occur with high affinity even though
the compound is not incorporated. In addition, incorporation
of non-nucleoside alkyltriphosphate analogues of the kind of
compounds Ia–c by DNA polymerase l occurs only opposite
to AP sites. Thus, non-nucleoside chain-terminating triphos-
phate analogues specific for AP sites, as the ones identified
in this study, warrant further development in light of their
potential biotechnological applications.
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